Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Neveu, Wendy A ^a   Allard, Jenna L ^b   Raymond, Danielle M ^b   Bourassa, Lorraine M ^b   Burns, Stephanie M ^b   Bunn, Janice Y ^a   Irvin, Charles G ^b   Kaminsky, David A ^b   Rincon, Mercedes ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN TH17; PROTEIN TH2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IL6 PROTEIN, HUMAN;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; MALE; PROTEIN ANALYSIS; PROTEIN FUNCTION; SPUTUM EXAMINATION; ASTHMA; IMMUNOLOGY; LUNG; PNEUMONIA; RESPIRATORY TRACT ALLERGY;

ADULT; ASTHMA; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; LUNG; MALE; PNEUMONIA; RESPIRATORY HYPERSENSITIVITY;

EID: 77952536377     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-28     Document Type: Article

References (46)

1. Georas SN, Guo J, De Fanis U, Casolaro V. T-helper cell type-2 regulation in allergic disease. Eur Respir J 2005, 26(6):1119-1137. 10.1183/09031936.05.00006005, 16319345.
2. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V, Fossiez F, Ryffel B, Schnyder B. Interleukin-17 is a negative regulator of established allergic asthma. The Journal of experimental medicine 2006, 203(12):2715-2725. 10.1084/jem.20061401, 2118159, 17101734.
3. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28(4):454-467. 10.1016/j.immuni.2008.03.004, 18400188.
4. Al-Ramli W, Al Samri M, Hamid Q. TH-17 cell-related cytokines' potential role in the pathogenesis of severe asthma. J Asthma 2008, 45(S1):41-44.
5. Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, Collins PD, Kay AB. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology 1992, 77(3):330-337. 1421719, 1478679.
6. King C, Brennan S, Thompson PJ, Stewart GA. Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. J Immunol 1998, 161(7):3645-3651.
7. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. The Journal of allergy and clinical immunology 1992, 89(5):1001-1009. 10.1016/0091-6749(92)90223-O, 1583242.
8. Kicic A, Sutanto EN, Stevens PT, Knight DA, Stick SM. Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. American journal of respiratory and critical care medicine 2006, 174(10):1110-1118. 10.1164/rccm.200603-392OC, 16908868.
9. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Reviews of physiology, biochemistry and pharmacology 2003, 149:1-38. full_text, 12687404.
10. Dienz O, Rincon M. The effects of IL-6 on CD4 T cell responses. Clinical immunology (Orlando, Fla) 2009, 130(1):27-33. 10.1016/j.clim.2008.08.018, 2660866, 18845487.
11. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science (New York, NY) 2003, 299(5609):1033-1036.
12. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441(7090):235-238. 10.1038/nature04753, 16648838.
13. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441(7090):231-234. 10.1038/nature04754, 16648837.
14. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24(2):179-189. 10.1016/j.immuni.2006.01.001, 16473830.
15. Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis and rheumatism 2007, 56(9):2936-2946. 10.1002/art.22866, 2323677, 17763419.
16. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature immunology 2007, 8(9):950-957. 10.1038/ni1497, 17676044.
17. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nature immunology 2007, 8(9):942-949. 10.1038/ni1496, 17676045.
18. Wang J, Homer RJ, Chen Q, Elias JA. Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J Immunol 2000, 165(7):4051-4061.
19. Doganci A, Eigenbrod T, Krug N, De Sanctis GT, Hausding M, Erpenbeck VJ, Haddad el B, Lehr HA, Schmitt E, Bopp T, Kallen KJ, Herz U, Schmitt S, Luft C, Hecht O, Hohlfeld JM, Ito N, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Renz H, Neurath MF, Galle PR, Finotto S. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. The Journal of clinical investigation 2005, 115(2):313-325. 544603, 15668741.
20. National Institutes of Health Highlights of the Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. 1997, 3. Washington, D.C.: DHHS, National Institutes of Health.
21. Standardization of Spirometry, 1994 Update. American Thoracic Society. American journal of respiratory and critical care medicine 1995, 152(3):1107-1136.
22. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. American journal of respiratory and critical care medicine 2000, 161(1):309-329.
23. Dixon AE, Raymond DM, Suratt BT, Bourassa LM, Irvin CG. Lower Airway Disease in Asthmatics with and without Rhinitis. Lung 2008, 186(6):361-368. 10.1007/s00408-008-9119-1, 2826710, 18843517.
24. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. The effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2009,
25. Woolhouse IS, Bayley DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002, 57(8):667-671. 10.1136/thorax.57.8.667, 1746392, 12149524.
26. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of personality and social psychology 1986, 51(6):1173-1182. 10.1037/0022-3514.51.6.1173, 3806354.
27. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P, Sim T, Ida N. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. American journal of respiratory and critical care medicine 1996, 153(4 Pt 1):1398-1404.
28. Neveu WA, Allard JB, Dienz O, Wargo MJ, Ciliberto G, Whittaker LA, Rincon M. IL-6 is required for airway mucus production induced by inhaled fungal allergens. J Immunol 2009, 183(3):1732-1738. 10.4049/jimmunol.0802923, 19592651.
29. Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, Woodworth T, Gomez-Reino JJ. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis and rheumatism 2008, 58(10):2968-2980. 10.1002/art.23940, 18821691.
30. Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, Woodworth T, Alten R. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 2008, 371(9617):987-997. 10.1016/S0140-6736(08)60453-5, 18358926.
31. Hacievliyagil SS, Gunen H, Mutlu LC, Karabulut AB, Temel I. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respiratory medicine 2006, 100(5):846-854. 10.1016/j.rmed.2005.08.022, 16214322.
32. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. American journal of respiratory and critical care medicine 1999, 159(2):487-494.
33. Stankiewicz W, Dabrowski MP, Chcialowski A, Plusa T. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma. Mediators of inflammation 2002, 11(5):307-312. 10.1080/09629350210000015719, 1781676, 12467523.
34. Diehl S, Krahl T, Rinaldi L, Norton R, Irvin CG, Rincon M. Inhibition of NFAT specifically in T cells prevents allergic pulmonary inflammation. J Immunol 2004, 172(6):3597-3603.
35. Whittaker L, Niu N, Temann UA, Stoddard A, Flavell RA, Ray A, Homer RJ, Cohn L. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. American journal of respiratory cell and molecular biology 2002, 27(5):593-602.
36. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science (New York, NY) 1998, 282(5397):2258-2261.
37. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. The Journal of clinical investigation 1999, 103(6):779-788. 10.1172/JCI5909, 408149, 10079098.
38. Shore SA, Moore PE. Effects of cytokines on contractile and dilator responses of airway smooth muscle. Clin Exp Pharmacol Physiol 2002, 29(10):859-866. 10.1046/j.1440-1681.2002.03756.x, 12207563.
39. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, Ceuppens JL. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respiratory research 2006, 7:135. 10.1186/1465-9921-7-135, 1636037, 17083726.
40. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF, Lipinska I, O'Connor GT, Benjamin EJ. Systemic inflammation and COPD: the Framingham Heart Study. Chest 2008, 133(1):19-25. 10.1378/chest.07-0058, 17908709.
41. Dixon AE, Shade DM, Cohen RI, Skloot GS, Holbrook JT, Smith LJ, Lima JJ, Allayee H, Irvin CG, Wise RA. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma 2006, 43(7):553-558. 10.1080/02770900600859123, 16939998.
42. Qiu Z, Fujimura M, Kurashima K, Nakao S, Mukaida N. Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen. Clin Exp Allergy 2004, 34(8):1321-1328. 10.1111/j.1365-2222.2004.02013.x, 15298576.
43. Kuhn C, Homer RJ, Zhu Z, Ward N, Flavell RA, Geba GP, Elias JA. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. American journal of respiratory cell and molecular biology 2000, 22(3):289-295.
44. De S, Zelazny ET, Souhrada JF, Souhrada M. IL-1 beta and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells. J Appl Physiol 1995, 78(4):1555-1563.
45. Ammit AJ, Moir LM, Oliver BG, Hughes JM, Alkhouri H, Ge Q, Burgess JK, Black JL, Roth M. Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. American journal of physiology 2007, 292(1):L199-206.
46. Alexis NE, Hu SC, Zeman K, Alter T, Bennett WD. Induced sputum derives from the central airways: confirmation using a radiolabeled aerosol bolus delivery technique. American journal of respiratory and critical care medicine 2001, 164(10 Pt 1):1964-1970.